πŸ“¦ Free Express Shipping on orders over $150 β€” Australia-wide
β€’ πŸ’Ž Save up to 22% β†’
Aventris Labs

Batch Verification Report

Batch verification and analytical summary for Elamipretide (SS-31 / MTP-131 β€” synthetic cardiolipin-targeting tetrapeptide reference material).

BVR ID: ELA-BVR-20260305
Revision: 1.0
Research Use Only
Product
Elamipretide (SS-31)
Composition
Elamipretide (SS-31)
Filler-free lyophilised peptide powder · No mannitol or bulking agents
Intended Use
Laboratory research and analytical reference applications only.
Batch & Dates
Manufacturer Lot: P260121-L004
Manufacture date: 21 Jan 2026
Recommended retest date: 20 Jan 2028
Form & Amount
Form: Lyophilised peptide powder (white)
Amount: As specified on Aventris product label
Storage
Store in a cool, dry place away from light. Follow Aventris storage guidance on the product label.

Analytical Results

The following analytical data was obtained from manufacturer testing of the source batch. Aventris has independently verified this data against our quality specifications. This Batch Verification Report summarises our review findings for Elamipretide (SS-31).

Elamipretide (SS-31) Lot P260121-L004  ·  Tetrapeptide  ·  Mw 639.8  ·  CAS 736992-21-5
TestMethodSpecificationResult
Purity (HPLC)HPLCβ‰₯99.0%99.74%
Peptide Content (N%)Nitrogen analysis (N%)β‰₯65.0%73.43%
Molecular Weight (ESI-MS)ESI-MS639.8 Β±1.0 DaConforms
Water Content (Karl Fischer)Karl Fischer≀10.0%2.38%
Acetate Content (HPLC)HPLC (ion chromatography)<26.0%20.43%
Assay (HPLC)HPLC95.0–105.0%96.24%
Bacterial EndotoxinsPharmacopoeial method<10 EU/mgConforms

Storage & Handling

Storage Conditions:

  • Store at −20°C or below in original sealed vial
  • Protect from light and moisture
  • Do not freeze-thaw repeatedly once reconstituted
  • Recommended shelf life: 24 months when stored properly

General Laboratory Handling:

  • Handle using standard laboratory safety practices
  • Wear appropriate personal protective equipment
  • Use in well-ventilated area or fume hood
  • Avoid inhalation, ingestion, or skin/eye contact

Reconstitution:
Reconstitution methods, diluents, and working concentrations must be determined by qualified researchers according to their specific experimental protocols and institutional guidelines. Aventris does not provide reconstitution instructions.

Peptide Sequence:

D-Arg – dimethyl-Tyr – Lys – Phe-NHβ‚‚
Tetrapeptide with D-Arg at N-terminus and C-terminal amide; dimethylated tyrosine at position 2

Molecular Identity:

  • C32H49N9O5 — MW 639.8 Da — CAS 736992-21-5

Additional Documentation:
For questions about this batch or to request additional information, contact [email protected]

Scroll to Top